Advanced glycation end product-induced activation of NF-κB is suppressed by α-lipoic acid in cultured endothelial cells

Diabetes

Volumn 46, Issue 9, 1997, Pages 1481-1490

  Bierhaus, Angelika ^a   Chevion, Shlomit ^a,d   Chevion, Mordechai ^d   Hofmann, Marion ^a   Quehenberger, Peter ^e   Illmer, Thomas ^b   Luther, Thomas ^b   Berentshtein, Eduard ^d   Tritschler, Hans ^c   Müller, Martin ^b   Wahl, Peter ^a   Ziegler, Reinhard ^a   Nawroth, Peter P ^a,f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ASTA MEDICA AG   (Germany)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e UNIVERSITY OF VIENNA   (Austria)

^f Medizinische Klinik I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN RADICAL; THIOCTIC ACID;

ANGIOGENESIS; ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARTICLE; CATTLE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DNA BINDING; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION;

EID: 2442631329     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.9.1481     Document Type: Article

References (54)

1. Vlassara H, Bucala, R, Striker L: Pathogenetic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
2. Yang Z, Makita Z, Horii Y, Brunelle S, Cerami A, Sehajpal P, Suthanthiran M, Vlassara H: Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucosemodified proteins. J Exp Med 174:515-524, 1991
3. Schmidt AM, Hori O, Brett J, Van SD, Wautier JL, Stem D: Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521-1528, 1994
4. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407, 1989
5. Vlassara H, Li Y-M, Imani F, Wojciechowicz D, Yang Z, Liu F-T, Cerami A: Identification of galectin-3 as a high affinity binding protein for advanced glycation end products (AGEs): a new member of the AGE-receptor complex. Mol Med 1:634-646, 1996
6. Schmidt AM, Mora R, Cao R, Yan SD, Brett J, Ramakrishnan R, Tsang TC, Simionescu M, Stem D: The endothelial cell binding site for advanced glycation end products consists of a complex: an integral membrane protein and a lactoferrin-like polypeptide. J Biol Chem 269:9882-9888, 1994
7. Schmidt A-M, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan Y-C, Tsang T, Stern D: Isolation and characterisation of binding proteins for advanced glycation end products from lung tissue which are present on the endothelial surface. J Biol Chem 267:14987-14997, 1992
8. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
9. Ritthaler U, Deng Y, Zhang Y, Greten J, Abel M, Sido B, Allenberg J, Otto G, Roth H, Bierhaus A, Ziegler R, Schmidt AM, Waldherr R, Wahl P, Stern DM, Nawroth PP: Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease. Am J Pathol 146:688-694, 1995
10. Abel M, Ritthaler U, Zhang Y, Deng Y, Schmidt A-M, Greten J, Sernau T, Wahl P, Andrassy K, Ritz E, Waldherr R, Stern DM, Nawroth PP: Expression of receptors for advanced glycosylated end products in renal disease. Nephrol Dial Transplant 10:1662-1667, 1995
11. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
12. Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Hori O, Zoukourian C, Capron L, Chappey O, Yan SD, Brett J, Guillausseau P-J, Stern DM: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 91:7742-7746, 1994
13. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern DM, Schmidt AM: Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97:238-243, 1996
14. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern DM: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96:1395-1403, 1995
15. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immun 12:141-179, 1994
16. Collins T: Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508, 1993
17. Godin DV, Wohaieb SA, Garnett ME, Goumeniouk AD: Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84:223-231, 1988
18. Packer L, Witt EH, Tritschler HJ: Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 19:227-250, 1995
19. Packer L: Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts. Ann NY Acad Sci 738:257-265, 1995
20. Suzuki YJ, Tsuchiya M, Packer L: Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 15:255-263, 1991
21. Busse E, Zimmer G, Schopohl B, Komhuber B: Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 42:829-831, 1992
22. Han D, Tritschler HJ, Packer L: α-lipoic acid increases intracellular glutathione in a human T-lymphocyte Jurkat cell line. Biochem Biophys Res Commun 207:258-264, 1995
23. Suzuki YJ, Aggarwal BB, Packer L: Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun 189:1709-1715, 1992
24. Suzuki YJ, Packer L: α-Lipoic acid is a potent inhibitor of NF-κB activation in human T cells: does the mechanism involve antioxidant activities? In New Strategies in Prevention and Therapy: Biological Oxidants and Antioxidants. Schmidt K, Packer L, Cadenas E, Eds. Stuttgart, Hippokrates Verlag, 1994, p. 87-97
25. Packer L, Suzuki YJ: Vitamin E and alpha-lipoate: role in antioxidant recycling and activation of the NF-kappa B transcription factor. Mol Aspects Med 14:229-239, 1993
26. Packer L: The role of anti-oxidative treatment of diabetes mellitus. Diabetologia 36:1212-1213, 1993
27. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J 10:706-720, 1996
28. Tesfamariam B: Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16:383-391, 1994
29. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-H326, 1992
30. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, Luther T, Müller M, Böhrer H, Greten J, Martin E, Baeuerle PA, Waldherr R, Kisiel W, Ziegler R, Stern DM, Nawroth PP: Mechanism of the TNFα mediated induction of endothelial tissue factor. J Biol Chem 270:26419-26432, 1995
31. Zhang YM, Deng Y, Luther T, Müller M, Ziegler R, Waldherr R, Stern D, Nawroth PP: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells. J Clin Invest 94:1320-1327, 1994
32. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aok N: Determination of plasma tissue factor antigen and its clinical significance in diabetes. Br J Haematol 87:343-347, 1994
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254, 1976
34. Mackman N, Fowler BJ, Edgington TS, Morrissey JH: Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci USA 87:2254-2258, 1990
35. Schwarte SM: Selection and characterization of bovine aortic endothelial cells. In Vitro 14:966-970, 1978
36. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D: Tumor necrosis factor/cachectin interacts with endothelial cells to induce release of interleukin-I. J Exp Med 163:1363-1375, 1986
37. Motchnik PA, Frei B, Ames BN: Measurements of antioxidants in human blood plasma. Methods Enzymol 234:269-279, 1994
38. Chevion S, Berry EM, Kitrossky N, Kohen R: Evaluation of plasma low molecular weight antioxidant capacity by cyclic voltammetry. Free Radic Biol Med 22:411-421, 1997
39. Nawroth PP, Stern DM, Kisiel W, Bach R: Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb Res 40:677-691, 1985
40. Bierhaus A, Zhang Y, Quehenberger P, Luther T, Haase M, Müller M, Mackman N, Ziegler R, Nawroth PP: The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB. Thromb Haemost 77:772-782, 1997
41. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R: Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 258:651-653, 1992
42. Suzuki YJ, Mizuno M, Tritschler HJ, Packer L: Redox regulation of NF-κB DNA binding activity by dihydrolipoate. Biochem Mol Biol Int 36:241-246, 1995
43. Suzuki YJ, Packer L: Inhibition of NF-kappa B DNA binding activity by alpha-tocopheryl succinate. Biochem Mol Biol Int 31:693-700, 1993
44. Nagaraj R, Monnier V: Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins. Biochim Biophys Acta 1253:75-84, 1995
45. Ceriello A, dello Russo P, Amstadt P, Cerutti P: High glucose induces antioxidant enzymes in human endothelial cells in culture: evidence linking hyperglycemia and oxidative stress. Diabetes 45:471-477, 1996
46. Schmidt AM, Hasu M, Popov D, Zhang JH, Chen J, Yan SD, Brett J, Cao R, Kuwabara K, Costache G, Stern D: The receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA 91:8807-8811, 1994
47. Suzuki YJ, Mizuno M, Packer L: Signal transduction for nuclear factor-κB activation: proposed location of an antioxidant-inhibitable step. J Immunol 153:153, 1994
48. Suzuki YJ, Packer L: Inhibition of NF-kappa B activation by vitamin E derivatives. Biochem Biophys Res Commun 193:277-283, 1993
49. Suzuki YJ, Packer L: Inhibition of NF-kappa B transcription factor by catechol derivatives. Biochem Mol Biol Int 32:299-305, 1994
50. Suzuki YJ, Tsuchiya M, Packer L: Lipoate prevents glucose-induced protein modifications. Free Radic Res Commun 17:211-217, 1992
51. Handelman GJ, Han D, Tritschler H, Packer L: α-lipoic acid reduction by mammalian cells to the dithiol form and release into the culture medium. Biochem Pharmacol 47:1725-1730, 1994
52. Haugaard N, Haugaard ES: Stimulation of glucose utilization by thioctic acid in rat diaphragm in vitro. Biochim Biophys Acta 222:583-586, 1970
53. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improve nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160-1167, 1995
54. Ziegler D, Hanefeld M, Ruhnau KJ, Meißner HP, Lobisch M, Schütte K, Gries FA, ALADIN Study Group: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. Diabetologia 38:1425-1433, 1995